These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


528 related items for PubMed ID: 26224790

  • 1. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
    Zhang L, Badve SV, Pascoe EM, Beller E, Cass A, Clark C, de Zoysa J, Isbel NM, McTaggart S, Morrish AT, Playford EG, Scaria A, Snelling P, Vergara LA, Hawley CM, Johnson DW, HONEYPOT Study Collaborative Group.
    Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
    [Abstract] [Full Text] [Related]

  • 2. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
    Htay H, Johnson DW, Wu SY, Oei EL, Foo MWY, Choo JCJ.
    Perit Dial Int; 2017 Dec; 37(3):266-272. PubMed ID: 28183858
    [Abstract] [Full Text] [Related]

  • 3. The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients.
    Johnson DW, Clark C, Isbel NM, Hawley CM, Beller E, Cass A, de Zoysa J, McTaggart S, Playford G, Rosser B, Thompson C, Snelling P, HONEYPOT Study Group.
    Perit Dial Int; 2009 Dec; 29(3):303-9. PubMed ID: 19458303
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
    Al-Hwiesh AK, Abdul-Rahman IS, Al-Muhanna FA, Al-Sulaiman MH, Al-Jondebi MS, Divino-Filho JC.
    Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
    [Abstract] [Full Text] [Related]

  • 9. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E, Passadakis P, Panagoutsos S, Bacharaki D, Euthimiadou A, Vargemezis V.
    Adv Perit Dial; 2000 Jul; 16():257-61. PubMed ID: 11045306
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study.
    McQuillan RF, Chiu E, Nessim S, Lok CE, Roscoe JM, Tam P, Jassal SV.
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):297-303. PubMed ID: 22134627
    [Abstract] [Full Text] [Related]

  • 13. Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population.
    Mahajan S, Tiwari SC, Kalra V, Bhowmik DM, Agarwal SK, Dash SC, Kumar P.
    Perit Dial Int; 2005 Feb; 25(5):473-7. PubMed ID: 16178481
    [Abstract] [Full Text] [Related]

  • 14. A Retrospective Sequential Comparison of Topical Application of Medicated Honey and Povidone Iodine for Preventing Peritoneal Dialysis Catheter-Related Infections.
    Wishart TFL, Aw L, Byth K, Rangan G, Sud K.
    Perit Dial Int; 2018 Feb; 38(4):302-305. PubMed ID: 29987066
    [Abstract] [Full Text] [Related]

  • 15. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
    Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L, Piraino B.
    J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-Term Exit-Site Gentamicin Prophylaxis and Gentamicin Resistance in a Peritoneal Dialysis Program.
    Chen SS, Sheth H, Piraino B, Bender F.
    Perit Dial Int; 2016 Feb; 36(4):387-9. PubMed ID: 26634567
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
    Campbell D, Mudge DW, Craig JC, Johnson DW, Tong A, Strippoli GF.
    Cochrane Database Syst Rev; 2017 Apr 08; 4(4):CD004679. PubMed ID: 28390069
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.